- Reports /
- Dialysis Market
Dialysis Market
Dialysis Market Market Research Report – Segmented By Type (HEMODIALYSIS, PERITONEAL DIALYSIS), By Products And Services (EQUIPMENT, CONSUMABLES, DIALYSIS DRUGS, SERVICES), By End-users (IN-CENTER DIALYSIS, HOME DIALYSIS) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Type
- By Products And Services
- By End-users
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Dialysis Market was valued at US $116.28 billion in 2021 and is projected to grow at 6.98% CAGR over the forecast period to reach US $174.29 billion by 2027. Dialysis Market represented US $14.67 billion opportunity over 2019-2021 and estimated to create US $58.01 billion opportunity in 2027 over 2021.
Dialysis from Consainsights analyses the Dialysis Market in the Life Sciences industry over the forecast period to 2027.
Dialysis research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Dialysis segmentation includes Type, Products And Services, End-users and Geography.
Based on the Type, the Dialysis analysis covers HEMODIALYSIS, PERITONEAL DIALYSIS.
In Type segment, HEMODIALYSIS segment has highest cagr growth of 6.18%.
Based on the Products And Services, the Dialysis analysis covers EQUIPMENT, CONSUMABLES, DIALYSIS DRUGS, SERVICES.
In Products And Services segment, EQUIPMENT segment has highest cagr growth of 6.18%.
Based on the End-users, the Dialysis analysis covers IN-CENTER DIALYSIS, HOME DIALYSIS.
In End-users segment, IN-CENTER DIALYSIS segment has highest cagr growth of 6.18%.
Based on the region, the Dialysis analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Type
Introduction
In 2021, PERITONEAL DIALYSIS segment has the highest revenue of US $72.93 billion and is expected to grow at CAGR of 6.18% by 2027 HEMODIALYSIS segment has highest cagr growth of 6.18%.
HEMODIALYSIS
HEMODIALYSIS segment was valued at US $37.88 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $64.98 billion by 2027. HEMODIALYSIS segment represented US $5.47 billion opportunity over 2019-2021 and estimated to create US $21.63 billion opportunity in 2027 over 2021.
PERITONEAL DIALYSIS
PERITONEAL DIALYSIS segment was valued at US $63.73 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $109.31 billion by 2027. PERITONEAL DIALYSIS segment represented US $9.20 billion opportunity over 2019-2021 and estimated to create US $36.38 billion opportunity in 2027 over 2021.
Products And Services
Introduction
In 2021, EQUIPMENT segment has the highest revenue of US $54.91 billion and is expected to grow at CAGR of 6.18% by 2027 EQUIPMENT segment has highest cagr growth of 6.18%.
EQUIPMENT
EQUIPMENT segment was valued at US $47.98 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $82.30 billion by 2027. EQUIPMENT segment represented US $6.93 billion opportunity over 2019-2021 and estimated to create US $27.39 billion opportunity in 2027 over 2021.
CONSUMABLES
CONSUMABLES segment was valued at US $29.90 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $51.28 billion by 2027. CONSUMABLES segment represented US $4.32 billion opportunity over 2019-2021 and estimated to create US $17.07 billion opportunity in 2027 over 2021.
DIALYSIS DRUGS
DIALYSIS DRUGS segment was valued at US $11.93 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $20.46 billion by 2027. DIALYSIS DRUGS segment represented US $1.72 billion opportunity over 2019-2021 and estimated to create US $6.81 billion opportunity in 2027 over 2021.
SERVICES
SERVICES segment was valued at US $11.80 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $20.25 billion by 2027. SERVICES segment represented US $1.70 billion opportunity over 2019-2021 and estimated to create US $6.74 billion opportunity in 2027 over 2021.
End-users
Introduction
In 2021, IN-CENTER DIALYSIS segment has the highest revenue of US $77.54 billion and is expected to grow at CAGR of 6.18% by 2027 IN-CENTER DIALYSIS segment has highest cagr growth of 6.18%.
IN-CENTER DIALYSIS
IN-CENTER DIALYSIS segment was valued at US $67.75 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $116.22 billion by 2027. IN-CENTER DIALYSIS segment represented US $9.79 billion opportunity over 2019-2021 and estimated to create US $38.68 billion opportunity in 2027 over 2021.
HOME DIALYSIS
HOME DIALYSIS segment was valued at US $33.86 billion in 2019 and is projected to grow at 6.18% CAGR over the forecast period to reach US $58.07 billion by 2027. HOME DIALYSIS segment represented US $4.89 billion opportunity over 2019-2021 and estimated to create US $19.33 billion opportunity in 2027 over 2021.